The Council for Medical Schemes (CMS) has suspended five officials over allegations of irregularities following anonymous tip-offs on its hotline. The medical schemes regulator said the employees, two executives and three senior managers, have all been placed on precautionary suspension with full pay following alleged irregularities, including corruption and unethical conduct reported by whistle-blowers.
The allegations, some of which predate the appointment of the current Registrar and Chief Executive, Dr Sipho Kabane, were also sent to local newspapers; the Ministry and Department of Health. The allegations include irregular placement of schemes under curatorship, irregular appointment of service providers, irregular spending on service providers with close relationship, having personal lifestyles not matched by salaries; having a close and corrupt relationship with entities regulated by CMS; breach of PFMA in respect of cover quoting, collusion in the appointment of service providers.
According to Dr Kabane all CMS executives will immediately be subjected to a lifestyle audit.
The suspensions follow only a few months after a general manager was suspended after serious allegations of corruption. The general manager has since resigned with immediate effect on the eve of the disciplinary hearing.
Dr Kabane said the council was cooperating with the Special Investigating Unit to investigate further allegations of fraud and corruption within the organisation and the industry. He said following a signed Presidential proclamation, this investigation was meant to shed light into the alleged corruption and serious maladministration in connection with the affairs of the council and this will be extended to the private sector.
“Also, when allegations of racial profiling, bullying and cohesion were presented to the CMS, a Steering Committee comprising of industry stakeholders, was convened. The steering committee collectively agreed to the establishment of an independent Investigating Panel to deal with allegations related to Section 59 of the Medical Schemes Act. The Section 59 investigation is ongoing, and recommendations will be made public later in the year,” Dr Kabane said, adding that a comprehensive report will be released in due course.